JAK-inhibitors as Therapeutic Strategy for Inflammatory Rheumatic Diseases

Massimo Gadina, PhD, Director of the Office of Science and Technology at National Institute of Arthritis Musculoskeletal and Skin Disease sammanfattar sin föreläsning JAK-inhibitors as Therapeutic Strategy for Inflammatory Rheumatic Diseases.